Travere Therapeutics Inc.

TVTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$62.86

+$0.10 (+0.16%)

At close: Sep 21, 2026, 4:00 PM ET

$61.23

-$1.63 (-2.59%)

Pre-market: Sep 22, 2026, 8:13 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	490.73M	233.18M	145.24M	109.46M	131.84M	198.32M
Cost of Revenue	10.34M	7.74M	11.45M	4.42M	3.82M	6.13M
Gross Profit	480.39M	225.43M	133.79M	105.04M	128.02M	192.2M
Operating Income	-62.82M	-323.83M	-388.14M	-319.81M	-199.43M	-176.16M
Interest Income	12.72M	17.82M	21.77M	6.28M	1.99M	5M
Pretax Income	-49.27M	-320.51M	-376.11M	-331.16M	-216.88M	-188.79M
Net Income	-25.55M	-321.55M	-111.4M	-278.48M	-180.09M	-169.43M
Selling & General & Admin	337.2M	264.12M	265.54M	197.52M	126.28M	135.8M
Research & Development	206.01M	282.7M	244.99M	227.33M	201.16M	131.77M
Other Expenses	n/a	2.44M	11.39M	n/a	n/a	100.79M
Operating Expenses	543.21M	549.26M	521.93M	424.85M	327.44M	368.36M
Interest Expense	10.75M	11.18M	11.33M	11.01M	19.68M	19.05M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	553.55M	557M	533.38M	429.27M	331.26M	374.48M
Income Tax Expense	988K	120K	223K	313K	409K	-19.36M
Shares Outstanding (Basic)	89.21M	78.89M	74.27M	63.76M	59.83M	47.54M
Shares Outstanding (Diluted)	89.21M	78.89M	74.27M	63.76M	59.83M	47.54M
EPS (Basic)	-0.56	-4.08	-1.50	-4.37	-3.01	-3.56
EPS (Diluted)	-0.56	-4.08	-1.50	-4.37	-3.01	-3.56
EBITDA	22.22M	-265.77M	-326.25M	-299.42M	-184.46M	-145.16M
EBIT	-38.53M	-309.33M	-364.78M	-320.14M	-197.2M	-169.74M
Depreciation & Amortization	60.74M	43.56M	38.53M	20.72M	12.75M	24.58M